Cody Parsons, APh, PharmD, BCCCP, says protected pharmacist access lets patients with heart failure be seen more often than typical clinic visits allow.
|Videos|October 19, 2021
The Role of Pharmacy Technicians Continues to Expand
Author(s)Ashley Gallagher, Editor
Meredith Ayers, CPhT, pharmacy technician at Bremo Pharmacy and presenter at the annual NCPA Convention 2021, discusses the expanding role of pharmacy technicians.
Advertisement
In a Pharmacy Times® interview, Meredith Ayers, CPhT, pharmacy technician at Bremo Pharmacy and presenter at the annual NCPA Convention 2021, discussed the expanding role of pharmacy technicians.
She talked about the tech-check-tech program, what certifications that pharmacy technicians can get, ways pharmacy technicians can advance their knowledge and education, and how technicians can advocate to keep the expanded responsibilities.
Advertisement
Related to this article
Post hoc AHA 2026 data show the oral GLP-1 receptor agonist lowered systolic blood pressure across hypertension stages, partly beyond weight loss.
Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
A pharmacy technician reflects on 3 patient encounters that reshaped his
understanding of what a real patient requires.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
How Stanford Pharmacists Help Close Heart Failure Therapy Gaps
3
GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers
4
GLP-1 Receptor Agonists and Cancer: Considerations for Specialty Pharmacists
5